A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects with Eosinophilic Esophagitis

Administered By

Medicine, Gastroenterology

Awarded By

Arena Pharmaceuticals, Inc.

Contributors

Leiman, David Asher Principal Investigator

Start/End

May 12, 2021 - April 25, 2024